SKIP INTRO

Analog & Digital Approaches to Better Patient Engagement

Patients and regulatory authorities are asking for more patient/sponsor communication over the drug development cycle. At the same time, many sponsors seek to better understand the value of different investments to meet this demand. They are converting patient insights into journey maps and case studies that are producing a variety of new technologies and services[…]

Pharmacovigilance Webinar: Avoid CAPAs and Enhance Health Authority Inspection Readiness

Anxious that your upcoming Health Authority Inspection will bring more CAPAs? Your organization spends a considerable amount of effort and resources on processing pharmacovigilance cases — but you’re still not sure your upcoming inspection will leave you without an additional CAPA headache. Ever wonder what it would be like to go into an inspection confident[…]

Patient Centricity – Improving Study Performance by Putting Patients First

Patient centricity ideas are everywhere today.  But, too often it is not seen by patients in a clinical trial. It seems like – the patient is at the center but the patients’ point of view is not. Patient Centricity – Sponsors vs. Patients Today, patients are asking for more input with sponsors throughout the drug development cycle.  And regulatory[…]

Webinar: Sample SharePoint Migration

Does your upcoming SharePoint migration feel like the proverbial millstone around your neck?  Do you break out into a cold sweat when someone mentions file migration? You are not alone.  Tackling a SharePoint Migration can be a daunting task – especially if your organization is migrating thousands of files.  But you do not have to[…]

Webinar: Practical Approaches to the EU Pharmacovigilance System Master File (PSMF)

The largest change in regulations in the European Union became fully effective in July 2015. It is not an understatement to say the Pharmacovigilance environment is changing at an unprecedented pace. These new regulations work to strengthen transparency and communication and enhance drug safety. However, transitioning to comply with these regulations can be a challenge.[…]

Decision Making in Big Pharma vs. Small Pharma

On many occasions, I have the opportunity to speak with leaders at small pharmaceutical and biotech companies. They always say, “We don’t operate like big pharma” or “I’m not interested in hearing the best practices from big pharma.” As a younger and less experienced leader from big pharma, I couldn’t fathom what they meant by[…]

Three Key Reasons to Switch to Interactive Data Visualization

Are you still using static visuals when interactive data visualization is available?  What is data visualization?!  I’m glad you asked. Data visualization is the presentation of information in a graphical form such that you can glean insights or make decisions.  It helps one communicate information effectively, efficiently and clearly. In today’s environment, traditional tools used[…]

Top 5 Reasons Why Your Biotech Needs a Project Manager

If you work at a biotech or small pharmaceutical company, you are under the microscope. You have investors waiting for the next bit of good news to raise confidence in your hard work. Your budget is limited because all funds are being used to accumulate that new data and generate the next press release. Your[…]

Laying the Foundation for Pharma Pipeline Decisions

It is well known that the days of Pharma thriving on blockbuster drugs are long gone. The drug development process is lengthy – currently spanning 15 years. And drugs on the market are coming off patent with few drugs to replace the significant revenue loss. As a result, measures to cut costs or just control[…]